Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers

被引:15
|
作者
Podczeck, F.
Course, N.
Newton, J. M.
Short, M. B.
机构
[1] Univ London, Sch Pharm, London WC1N 1AX, England
[2] Univ Sunderland, Sch Hlth Nat & Social Sci, Sunderland SR1 3SD, England
[3] UCL, Dept Med Phys, London WC2E 6AD, England
关键词
D O I
10.1211/jpp.59.7.0005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to compare the gastrointestinal transit of multiple unit, small diameter (3.2 mm), non-disintegrating tablets of differing densities with results previously reported in the same volunteers in the fasted state for larger diameter (6.6 and 12.2 mm) tablets. The gastrointestinal transit was observed with gamma-scintigraphy at various intervals over a 9-h period to give an accurate.assessment of the transit characteristics. The value for-the median emptying time of the first light tablet was significantly shorter than that for the dense tablet, but the total emptying time and the time for the last tablet to empty for both sets of tablets were not statistically different. The value of the median time for initial and final emptying of the small tablets from the stomach was significantly longer than that for the larger diameter tablets. The 9-h time limit of the observations limited the estimation of the time taken to enter the caecum and consequently the small intestine transit times. There was clear evidence that for the dense tablets of all sizes, the value for the small intestine transit time was longer than the 3-4 h reported in the literature. The only tablet system to enter the caecum within the time limit of the study was the normal density 12.2-mm tablets.
引用
收藏
页码:941 / 945
页数:5
相关论文
共 50 条
  • [31] Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug
    Rosca, I. D.
    Vergnaud, J. M.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2010, 35 (1-2) : 29 - 39
  • [32] Controlled-release oral dosage forms containing nimodipine solid dispersion and hydrophilic carriers
    Lee, Hyo-Jung
    Kim, Ju-Young
    Park, Sung-Hoon
    Rhee, Yun-Seok
    Park, Chun-Woong
    Park, Eun-Seok
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 37 : 28 - 37
  • [33] Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug
    I. D. Rosca
    J. M. Vergnaud
    European Journal of Drug Metabolism and Pharmacokinetics, 2010, 35 : 29 - 39
  • [34] Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices
    Veiga, F
    Salsa, T
    Pina, ME
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (01) : 1 - 9
  • [35] Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques
    Genina, Natalja
    Fors, Daniela
    Vakili, Hossein
    Ihalainen, Petri
    Pohjala, Leena
    Ehlers, Henrik
    Kassamakov, Ivan
    Haeggstrom, Edward
    Vuorela, Pia
    Peltonen, Jouko
    Sandler, Niklas
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (03) : 615 - 623
  • [36] REPORT OF THE WORKSHOP ON - INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED RELEASE DOSAGE FORMS
    SKELLY, JP
    AMIDON, GL
    BARR, WH
    BENET, LZ
    CARTER, JE
    ROBINSON, JR
    SHAH, VP
    YACOBI, A
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (02) : 83 - 93
  • [37] THE ROLE OF CLINICAL-PHARMACOLOGY IN THE DEVELOPMENT AND EVALUATION OF ORAL CONTROLLED-RELEASE DOSAGE FORMS
    KENDALL, MJ
    JOHN, VA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 : S65 - S67
  • [38] Esophageal transit of solid oral dosage forms - impact of different surface materials characterized in vitro and in vivo by MRI in healthy volunteers
    Hummler, Henriette
    Page, Susanne
    Stillhart, Cordula
    Lorenz, Phil
    Kromrey, Marie-Luise
    Weitschies, Werner
    Grimm, Michael
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 203
  • [39] CONTROLLED-RELEASE DOSAGE FORMS AND GASTROINTESTINAL BLOOD-LOSS - 4 CLINICAL-STUDIES
    MCMAHON, FG
    VARGAS, R
    LEESE, P
    CRAWFORD, B
    KONECNY, A
    NICHOLS, K
    KNOWLES, M
    THEEUWES, F
    GUINTA, D
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (01) : 75 - 84
  • [40] Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid
    Agarwal, Vikas
    Nazzal, Sami
    Khan, Mansoor A.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2008, 13 (04) : 291 - 298